Егистрозол

Егистрозол (Anastrozole) is an oral medication used for hormone receptor-positive breast cancer treatment in postmenopausal women. This aromatase inhibitor helps reduce estrogen levels to slow tumor growth. Suitable for long-term therapy under medical supervision.

Егистрозол is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which can help slow or stop the growth of certain types of breast cancer cells. This medication is often prescribed after surgery or other treatments to reduce the risk of cancer recurrence.

Users of Егистрозол may experience common effects such as hot flashes, fatigue, joint pain, or mild nausea. Some individuals report mood changes or headaches, though these are typically temporary. Bone density may also be affected, so regular monitoring is often recommended.

Егистрозол should be taken exactly as prescribed by a healthcare provider. It is important to discuss your full medical history, including bone health and any ongoing medications, before starting this treatment. Regular check-ups are advised to monitor treatment progress and adjust therapy if needed.

Certain medications may interact with Егистрозол, including estrogen-containing drugs, tamoxifen, and some antidepressants. Alcohol and grapefruit products may also affect how the medication works. Always inform your doctor about all medications and supplements you are taking to avoid potential interactions.